Evidence map›Paper›PMID 39034830›Full record

ReviewCentral nervous system agents in medicinal chemistry2024

A Comprehensive Review of the Pharmacological Effects of Genus Ferula on Central Nervous System Disorders.

Seyyed Majid Bagheri, Mansour Esmailidehaj

Abstract readReview
PubMed Publisher
In one paragraph

Review in Central nervous system agents in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Seyyed Majid BagheriDepartment of Physiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID 0000-0003-0107-7141
Mansour EsmailidehajDepartment of Physiology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID 0000-0001-6869-0966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlants of the genus Ferula have long been used to treat neurological diseases such as Alzheimer's disease (AD), pain, depression, and seizures. The main compounds include coumarins, monoterpenes, sulfide compounds, and polyphenol compounds, which can improve the functioning of the nervous system.

objectiveThis article has been compiled with the aim of collecting evidence and articles related to the Ferula effects on central nervous system disease.

methodsThis review article was prepared by searching the terms Ferula and analgesic, anticonvulsant, antidepressant, anti-multiple sclerosis, anti-dementia, and neuroprotective effects.The relevant information was collected through searching electronic databases such as ISI Web of Knowledge, PubMed, and Google Scholar.

resultsGenus Ferula has a protective effect on nerve cells by reducing cytokines such as IL-6, IL- 1b, and TNF-α. Therefore, the effects of Ferula plants and their effective ingredients can be used to prevent or improve diseases that destroy the nervous system. The members of this genus play a role in strengthening and improving the antioxidant system, reducing the level of oxidative stress, and inhibiting or reducing inflammatory factors in the nervous system.

conclusionAlthough the effects of several species of Ferula on the nervous system have been investigated, most studies have not clearly identified the molecular mechanisms as well as the specific functional regions of the brain. The present study was compiled in order to investigate different aspects of the effects of Ferula plants on the central nervous system.

Indexed as

Central Nervous System DiseasesFerulaAnimalsHumansNeuroprotective AgentsPlant ExtractsNeuroprotective AgentsPlant Extractsanticonvulsantanti-dementia.antidepressantantinociceptiveFerulaneuroprotective

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.